arrow
K

Koshiro Kanaoka

national cerebral and cardiovascular center
H指数:19
被引数:1,240
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of Catheter Ablation for Atrial Fibrillation During Hospitalisation for Acute Heart Failure: A Nationwide Analysis From the JROAD-DPC Database

急性心力衰竭住院期间进行心房颤动导管消融的安全性:来自JROAD-DPC数据库的全国性分析

2026-09-230
OAAI
Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

心肌炎和炎性心肌病心律失常的处理与管理:欧洲心律协会和ESC心力衰竭协会、ESC心肌与心包疾病工作组、ESC预防心脏病学协会、心律学会、亚太心律学会和拉丁美洲心律学会的临床共识声明

2026-08-280
OAAI
Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

心肌炎和炎症性心肌病心律失常的处理与管理:欧洲心律学会、ESC心力衰竭学会、ESC心肌与心包疾病工作组、ESC预防心脏病学协会、心律学会、亚太心律学会和拉丁美洲心律学会的临床共识声明

2026-08-280
OA
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies

心力衰竭临床实践和结局的时间比较:JROADHF和JROADHF-NEXT研究

2026-08-080
PRE
Differential impact of institutional procedural volume on outcomes of transcatheter and surgical strategies for concomitant aortic stenosis and coronary artery disease: a nationwide registry study

不同机构手术量对同时性主动脉瓣狭窄和冠状动脉疾病经导管与外科治疗策略结局的影响:一项全国登记研究

2026-06-300
PRE
Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy ― Insights from the REVIEW-HF Registry

沙库巴曲缬沙坦在转甲状腺素蛋白淀粉样变性心肌病患者中的相关不良事件和药物停用情况 ― 来自REVIEW-HF登记研究的见解

2026-05-010
PRE
Impact of a provider-level incentive on smoking cessation treatment use: A secondary dataset analysis using administrative claims data and a cross-sectional survey in Japanese health check-up settings (N-EQUITY2203 )

提供者层面激励对戒烟治疗使用的影响:基于日本健康检查设置中行政索赔数据和横断面调查的二次数据集分析(N-EQUITY2203)

2026-05-010
OA
Guideline-directed medical therapy and hypotension after initiation of vericiguat: Insights from the VERIFY-HF study

基于VERIFY-HF研究的指导性医疗疗法与启动vericiguat后的低血压:洞见

2026-03-260
OAAI
Annual Trends and Regional Disparities in Transvenous Lead Extractions in Japan: Insights From the Nationwide Japanese Registry of All Cardiac and Vascular Diseases-Diagnostic Procedure Combination Data

日本经静脉导线移除术的年度趋势及区域差异:来自日本全国所有心血管疾病登记数据库-诊断程序组合数据的见解

2026-02-010
OAAI
Trends and factors associated with potentially inappropriate medication use in older adults hospitalized for heart failure: A nationwide analysis using the JROAD-DPC database

心力衰竭住院老年患者潜在不适当用药的趋势及相关因素:一项基于JROAD-DPC数据库的全国性分析

2025-12-110
PRE
The Japanese Lead Extraction Registry (J-LEX): Annual Report in 2024

日本导线拔除登记系统(J-LEX):2024年度报告

2025-12-010
OAAI